The role of folate transport and metabolism in neural tube defect risk

被引:51
作者
Barber, RC
Lammer, EJ
Shaw, GM
Greer, KA
Finnell, RH [1 ]
机构
[1] Texas A&M Univ, Dept Vet Anat & Publ Hlth, Coll Vet Med, College Stn, TX 77843 USA
[2] Texas A&M Univ, Ctr Environm & Rural Hlth, College Stn, TX 77843 USA
[3] Childrens Hosp, Div Med Genet, Oakland, CA 94609 USA
[4] March Dimes Birth Defect Fdn, Calif Birth Defects Monitoring Program, Oakland, CA 94608 USA
关键词
neural tube defects; folic acid; folate metabolism; folate transport; methylenetetrahydrofolate reductase; methionine synthase; folate receptor alpha;
D O I
10.1006/mgme.1998.2787
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Neural tube defects (NTDs) are common congenital malformations in humans. While etiologically heterogeneous, for the most part they are multifactorial in their pathogenesis, having both genetic and environmental factors contributing to their development. In recent years, there has been a great deal of epidemiologic evidence demonstrating that women who received multivitamins containing folic acid periconceptionally had significantly reduced occurrence and recurrence risks for producing infants with such malformations. Unfortunately, the mechanism(s) underlying the beneficial effects of folic acid is not well understood. In this article, we review the fundamental embryological processes involved in closing the neural tube, the relevant epidemiologic data on folic acid supplementation and relative NTD risk, as well as several recent studies of candidate genes for NTD sensitivity that are involved in folate transport and metabolism. (C) 1999 Academic Press.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 75 条
  • [21] HUNTER AGW, 1993, HUMAN MALFORMATIONS, P109
  • [22] Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations
    Jacques, PF
    Bostom, AG
    Williams, RR
    Ellison, RC
    Eckfeldt, JH
    Rosenberg, IH
    Selhub, J
    Rozen, R
    [J]. CIRCULATION, 1996, 93 (01) : 7 - 9
  • [23] KAMEN BA, 1988, J BIOL CHEM, V263, P13602
  • [24] THE FOLATE RECEPTOR WORKS IN TANDEM WITH A PROBENECID-SENSITIVE CARRIER IN MA 104 CELLS-INVITRO
    KAMEN, BA
    SMITH, AK
    ANDERSON, RGW
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (04) : 1442 - 1449
  • [25] KANE MA, 1989, LAB INVEST, V60, P737
  • [26] KHOURY MJ, 1982, AM J HUM GENET, V34, P980
  • [27] Methylenetetrahydrofolate reductase mutation and neural tube defects
    Kirke, PN
    Mills, JL
    Whitehead, AS
    Molloy, A
    Scott, JM
    [J]. LANCET, 1996, 348 (9033) : 1037 - 1038
  • [28] COMPLEMENTARY-DNA FOR THE FOLATE BINDING-PROTEIN CORRECTLY PREDICTS ANCHORING TO THE MEMBRANE BY GLYCOSYL-PHOSPHATIDYLINOSITOL
    LACEY, SW
    SANDERS, JM
    ROTHBERG, KG
    ANDERSON, RGW
    KAMEN, BA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (02) : 715 - 720
  • [29] Langman J., 1981, MED EMBRYOLOGY
  • [30] DOUBLE-BLIND RANDOMIZED CONTROLLED TRIAL OF FOLATE TREATMENT BEFORE CONCEPTION TO PREVENT RECURRENCE OF NEURAL-TUBE DEFECTS
    LAURENCE, KM
    JAMES, N
    MILLER, MH
    TENNANT, GB
    CAMPBELL, H
    [J]. BRITISH MEDICAL JOURNAL, 1981, 282 (6275) : 1509 - 1511